Variable | Value |
---|---|
Sex, n(%) | |
Female | 145 (53.3%) |
Male | 127 (46.7%) |
Age in yrs | 42.56 ± 16.18 |
BMI (kg/m2) | 23.28 ± 3.49 |
Symptom duration in mos | 19.65 (0–240) |
Presenting symptoms | |
Back pain, n(%) | 152 (55.9%) |
Motor weakness, n (%) | 139 (51.1%) |
Sensory abnormal, n (%) | 108 (39.7%) |
Sphincter disturbances, n (%) | 47 (17.3%) |
Median preop MMS score (IQR) | 3 (2–3) |
Location, n (%) | |
Cervical | 50 (18.4%) |
Cervicothoracic | 20 (7.4%) |
Thoracic | 103 (37.9%) |
Thoracolumbar | 29 (10.7%) |
Lumbar | 70 (25.7%) |
Vertebral levels of tumor involvement, n (%) | |
1 | 69 (25.4%) |
2 | 136 (50%) |
3 | 39 (14.3%) |
4 | 15 (5.5%) |
5 | 3 (1.1%) |
6 | 2 (0.7%) |
7 | 4 (1.5%) |
8 | 1 (0.4%) |
12 | 3 (1.1%) |
Previous treatment, n(%) | |
Biopsy | 4 (1.5%) |
Chemotherapy | 1 (0.4%) |
Preop spinal deformity, n(%) | |
No | 275 (97.4%) |
Yes | 7 (2.6%) |
Postop spinal deformity, n(%) | |
No | 229 (84.2) |
Yes | 43 (15.8) |